<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000550.v1.p1" parentStudy="phs000550.v1.p1" createDate="2012-09-28" modDate="2013-01-24">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Winnie S. Liang, PhD</td><td>Translational Genomics Research Institute, Phoenix, AZ, USA</td></tr>
		<tr><td>Co-Investigator</td><td>David W. Craig, PhD</td><td>Translational Genomics Research Institute, Phoenix, AZ, USA</td></tr>
		<tr><td>Co-Investigator</td><td>John Carpten, PhD</td><td>Translational Genomics Research Institute, Phoenix, AZ, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Mitesh J. Borad, MD</td><td>Translational Genomics Research Institute, Phoenix, AZ, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Daniel Von Hoff, MD</td><td>Translational Genomics Research Institute, Phoenix, AZ, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Characterization of Pancreatic Adenocarcinoma Patients Using NGS</StudyNameEntrez>
	<StudyNameReportPage>Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>In this study, we whole genome sequenced tumor/normal pairs from three pancreatic adenocarcinoma patients to separately characterize each patient with respect to somatic alterations. For 2 patients for whom tumor RNA was available, we also performed RNA sequencing to evaluate gene expression changes. While additional sequencing is needed to improve our understanding of the disease, the information acquired from this study contributes to our knowledge base on pancreatic cancer and helps to establish a foundation for identifying and developing more efficacious treatments for patients.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Inclusion criteria: patients had to be &#8805; 18 years of age and provided signed informed consent. These patients included those with a pathologic or clinical diagnosis of a pancreatic malignant neoplasm, or who were undergoing a medically indicated procedure to obtain tissue or to resect their pancreatic tumor. Other eligibility criteria included: Karnofsky performance status (PS) &#8805; 80%, life expectancy &#62; 3 months, baseline laboratory data indicating acceptable bone marrow reserve, liver, and renal function.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="23071490"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Pancreatic Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Carcinoma"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Winnie S. Liang, PhD</AttName>
			<Institution>Translational Genomics Research Institute, Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>David W. Craig, PhD</AttName>
			<Institution>Translational Genomics Research Institute, Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>John Carpten, PhD</AttName>
			<Institution>Translational Genomics Research Institute, Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Mitesh J. Borad, MD</AttName>
			<Institution>Translational Genomics Research Institute, Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Daniel Von Hoff, MD</AttName>
			<Institution>Translational Genomics Research Institute, Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>P01 CA109552</AttName>
			<Institution>United States Department of Health and Human Services, Washington, DC, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>This study was carried out using samples collected between 2010 and 2011. The research was performed between 2010 and 2012.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000550.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000550.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000550.v1.p1" FileName="eNCI_0142_DUC_7.31.2012.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data set is limited to research purposes only.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
